COVID - 19 Vaccination Update - Day 603 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 39 Second

Posted On: 10 SEP 2022 8:26PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 214.92 Crore (2,14,92,85,050) today. More than 14 lakh (14,14,849) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10414498
	2^nd Dose	10110699
	Precaution Dose	6865728
FLWs	1^st Dose	18435523
	2^nd Dose	17705508
	Precaution Dose	13361487
Age Group 12-14 years	1^st Dose	40620815
	2^nd Dose	30836454
Age Group 15-18 years	1^st Dose	61790416
	2^nd Dose	52641763
Age Group 18-44 years	1^st Dose	560881231
	2^nd Dose	514230298
	Precaution Dose	75970353
Age Group 45-59 years	1^st Dose	203957652
	2^nd Dose	196583904
	Precaution Dose	40814415
Over 60 years	1^st Dose	127619835
	2^nd Dose	122889367
	Precaution Dose	43555104
Cumulative 1^st dose administered		1023719970
Cumulative 2^nd dose administered		944997993
Precaution Dose		180567087
Total		2149285050

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 10^thSeptember, 2022 (603^rdDay)
HCWs	1^st Dose	22
	2^nd Dose	175
	Precaution Dose	5967
FLWs	1^st Dose	62
	2^nd Dose	253
	Precaution Dose	11920
Age Group 12-14 years	1^st Dose	17272
	2^nd Dose	38640
Age Group 15-18 years	1^st Dose	7792
	2^nd Dose	20062
Age Group 18-44 years	1^st Dose	15933
	2^nd Dose	64140
	Precaution Dose	747774
Age Group 45-59 years	1^st Dose	2562
	2^nd Dose	14194
	Precaution Dose	310355
Over 60 years	1^st Dose	1618
	2^nd Dose	9796
	Precaution Dose	146312
Cumulative 1^st dose administered		45261
Cumulative 2^nd dose administered		147260
Precaution Dose		1222328
Total		1414849

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.